All our tutorials are approved by the VOICE Program of the Society of Nuclear Medicine, the only approval accepted by the State of California. Listed here are the titles of the tutorials available as well as their scopes as assigned by the VOICE Program.
Information for California Nuclear Medicine Technologists
New VOICE approved Tutorials Available 11/1/23:
- AMYVID (Florbetapir F-18) for Evaluation of Alzheimer’s Patients
- DaTscan (Ioflupane I 123 Injection) for Parkinsonian Syndrome
- Fluoroestradiol F-18 for Detection of ER + lesions in breast cancer
- Gamma Counters in Nuclear Medicine: Design and Operation
- Instrumentation for Detection of Ionizing Radiation
- Lu-177 PSMA Therapy for Metastatic Prostate Cancer
- Lutathera Therapy for Treatment of Neuroendocrine Tumors
- Lymphoseek Tc-99m for Lymphatic Mapping
- PET & PET/CT Instrumentation: Performance & Quality Control
- PET Radiopharmaceuticals Version 2023
| THERAPY CREDITS | ||
| Session Title | CA Scope | TOTAL CEUs |
| Lu-177 PSMA Therapy for Metastatic Prostate Cancer | 2T | 2 |
| Lutathera Therapy for Treatment of Neuroendocrine Tumors | 3 T | 3 |
| Palliation of Pain from Bony Metastases | 1 T | 1 |
| Radionuclide Therapy | 2 T | 2 |
| Radionuclide Therapy: Radiation Safety Precautions | 3 T | 3 |
| RIT of Non-Hodgkins Lymphoma | 2 T | 2 |
| SIRT for Treatment of Liver Cancer | 2 T | 2 |
| XOFIGO (Ra-223 Chloride) for Palliation of Pain in Prostate Cancer Patients | 2 T, 1 R | 3 |
| NON-IMAGING CREDITS | ||
| Session Title | CA Scope | TOTAL CEUs |
| Atomic and Nuclear Structure: The Basics | 2 NI | 2 |
| Attenuation of Radiation: Concept and Mathematics | 1 NI, 1 R | 2 |
| Current NRC Regulations & Hot Lab QC | 2 NI, 1R | 3 |
| Gamma Counters: Design and Operation | 2 NI, 1R | 2 |
| In Vivo Non-Imaging Procedures | 1 NI | 1 |
| Instrumentation for Detection of Ionizing Radiation | 3 NI | 3 |
| Interaction of Ionizing Radiation with Matter | 2 NI, 1R | 2 |
| Inverse Square Law | NI | 1 |
| Modes of Decay | 1 NI, 1 R | 2 |
| Personnel Monitoring Devices | 1 NI, 1 R | 2 |
| Radioactive Decay: Concepts and Mathematical Applications | 1 NI, 1 R | 2 |
| Surviving An Inspection | 1 NI | 1 |
| IMAGING CREDITS | ||
| Session Title | CA Scope | TOTAL CEUs |
| Blood Pool Imaging with Tc-99m RBCs | 1 I; 1 R | 2 |
| DATSCAN for Diagnosis of Parkinsonian Syndrome | 1 I; 1 R | 2 |
| FLUOROESTRADIOL for detection of ER+ Breast Cancer | 1 I; 1 R | 2 |
| Gastric Emptying Studies Using Tc-99m Meals | 1 I; 1 R | 2 |
| Hepatobiliary Imaging Using Tc-99m IDA Compounds | 1 I; 1 R | 2 |
| Image Fusion | 1 I | 1 |
| Imaging of Neuroendocrine tumors | 1 I; 1 R | 2 |
| Instrumentation for Detection of Ionizing Radiation | 2 NI, 1 I | 3 |
| Lymphoscintigraphy | 1 I | 1 |
| LYMPHOSEEK for lymph node mapping | 1 I; 1 R | 2 |
| Molecular Imaging | 1 I | 1 |
| Neuroendocrine Tumor Imaging | 2 I | 2 |
| PET & PET/CT Instrumentation: Performance and quality control | 1I, 2 NI | 3 |
| PET Radiopharmaceuticals Comprehensive Overview | 1.5 R, 0.5 I | 2 |
| Prostate Cancer Imaging with F-18 Fluciclovine | 1 I; 1 R | 2 |
| Pulmonary Perfusion Imaging Using Tc-99m MAA | 1 I; 1 R | 2 |
| Skeletal Imaging with Tc-99m Phosphates and F-18 NaF | 1 I; 1 R | 2 |
| Thyroid Imaging with Tc-99m Pertechnetate and I-123 NaI | 1 I; 1 R | 2 |
| Thyroid Uptake Test using I-123 NaI | 1 I; 1 R | 2 |
| Tumor Imaging with F-18 FDG | 1 I; 1 R | 2 |
| RADIOPHARMACY CREDITS | ||
| Session Title | CA Scope | TOTAL CEUs |
| Blood Pool Imaging with Tc-99m RBCs | 1 I; 1 R | 2 |
| Cardiac Radiopharmaceuticals | 2 R | 2 |
| Cell Labeling | 1 R | 1 |
| Clinically Useful Radionuclides: Diagnosis and Therapy | 1 R | 1 |
| DATSCAN for Diagnosis of Parkinsonian Syndrome | 1 I; 1 R | 2 |
| Dose Calibrator Operation and Quality Control Testing | 1 R | 1 |
| FLUOROESTRADIOL for detection of ER+ Breast Cancer | 1 I; 1 R | 2 |
| Gastric Emptying Studies Using Tc-99m Meals | 1 I; 1 R | 2 |
| Half-Lives: Physical, Biological, and Effective | 1 R | 1 |
| Hepatobiliary Imaging Using Tc-99m IDA Compounds | 1 I; 1 R | 2 |
| Imaging of Neuroendocrine tumors | 1 I; 1 R | 2 |
| LYMPHOSEEK for lymph node mapping | 1 I; 1 R | 2 |
| Mechanisms of Localization of Radiopharmaceuticals | 1 R | 1 |
| PET & PET/CT Instrumentation: Performance and quality control | 1I, 2 NI | 3 |
| PET Radiation Safety | 1 R | 1 |
| PET Radiopharmaceuticals | 1 R | 1 |
| PET Radiopharmaceuticals Comprehensive Overview | 1.5 R, 0.5 I | 2 |
| PET Radiopharmaceuticals Comprehensive Overview | 1.5 R, 0.5 I | 2 |
| Prostate Cancer Imaging with F-18 Fluciclovine | 1 I; 1 R | 2 |
| Pulmonary Perfusion Imaging Using Tc-99m MAA | 1 I; 1 R | 2 |
| Quality Control in the Hot Lab | 0.25 NI, 0.75 R | 1 |
| Radiation Dosimetry | 1 R | 1 |
| Radionuclide Generators | 1 R | 1 |
| Radiopharmaceuticals | 2 R | 2 |
| Skeletal Imaging with Tc-99m Phosphates and F-18 NaF | 1 I; 1 R | 2 |
| Thyroid Imaging with Tc-99m Pertechnetate and I-123 NaI | 1 I; 1 R | 2 |
| Thyroid Uptake Test using I-123 NaI | 1 NI, 1 R | 2 |
| Tumor Imaging with F-18 FDG | 1 I; 1 R | 2 |
| XOFIGO (Ra-223 Chloride) for Palliation of Pain in Prostate Cancer Patients | 2 T, 1 R | 3 |
| All tutorials and quizzes are being published in the easiest way for everyone to access them. If you are a Student in Nuclear Medicine– our tutorials and quizzes are available at no charge. CE Credit does not apply to students until they are licensed by their State Department of Nuclear Safety or the US NRC. | ||